A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MMP-9

Search Conditions:
Search Keyword : MMP-9
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MMP-9
Appearance Frequency: 4200 time(s)
Long forms: 33

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
matrix metalloproteinase-9
(4162 times)
Neoplasms
(542 times)
TIMP-1 (324 times)
VEGF (259 times)
TNF-alpha (256 times)
1992 Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
matrix metalloproteinase-9, gelatinase B
(4 times)
Molecular Biology
(2 times)
ELISA (1 time)
IA (1 time)
OA (1 time)
1996 Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
metallomatrix proteinase-9
(2 times)
Biochemistry
(1 time)
APP (1 time)
BA (1 time)
CAT (1 time)
2009 Transgelin: an actin-binding protein and tumour suppressor.
migration marker proteins matrix metalloproteinase-9
(2 times)
Neoplasms
(2 times)
BAMBI (1 time)
ESCC (1 time)
HAS1 (1 time)
2017 HNF1A‑AS1 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging miR‑214 to upregulate the expression of SOX-4.
MMP-9 KO
(2 times)
Biology
(1 time)
MMP-2 (3 times)
WT (2 times)
AAA (1 time)
2002 Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.
(CypA)-Matrix metallopeptidase-9
(1 time)
Molecular Biology
(1 time)
APOE (1 time)
BBB (1 time)
CypA (1 time)
2018 Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury.
makes measurement of salivary metalloproteinase-9
(1 time)
Dentistry
(1 time)
AUC (1 time)
IQR (1 time)
OSCC (1 time)
2017 Salivary MMP-9 in the detection of oral squamous cell carcinoma.
matrix and secrete high levels of 92-kd metalloproteinase
(1 time)
Allergy and Immunology
(1 time)
HIV (1 time)
1995 Interferon-gamma inhibits HIV-induced invasiveness of monocytes.
matrix metallopeptidase-9 in tumor tissues
(1 time)
Neoplasms
(1 time)
EGFR-TKI (1 time)
mTOR (1 time)
NSCLC (1 time)
2014 Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.
10  matrix metalloproteinase-2 and -9
(1 time)
Pharmacology
(1 time)
BMMs (1 time)
JNK (1 time)
LPS (1 time)
2016 Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
11  matrix-degrading metalloproteinase-9
(1 time)
Allergy and Immunology
(1 time)
RA (1 time)
SF (1 time)
1996 Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.
12  metalloprotease MMP-9
(1 time)
Otolaryngology
(1 time)
uPA (1 time)
1998 An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
13  metalloproteinase-9 in serum
(1 time)
Medicine
(1 time)
--- 2005 [Influence of Broncho-Vaxom treatment on serum concentration of metalloproteinase-9 in patients with chronic obstructive pulmonary disease].
14  metalloproteinases in general and specially gelatinase B/metalloproteinase-9
(1 time)
Multiple Sclerosis
(1 time)
MS (1 time)
2017 Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease.
15  metastatic propensity, namely, metalloproteinase-9
(1 time)
Neoplasms
(1 time)
TIMP-2 (1 time)
VEGF (1 time)
2000 Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle.
16  microglial markers and metalloproteinase-9
(1 time)
Allergy and Immunology
(1 time)
--- 2014 Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model.
17  MMP 92-kDa type IV collagenase
(1 time)
Molecular Biology
(1 time)
MMP (1 time)
SCC (1 time)
1997 Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma.
18  MMP activity by 490 +/- 30
(1 time)
Neurology
(1 time)
AVMs (1 time)
MMP (1 time)
sEng (1 time)
2009 Soluble endoglin modulates aberrant cerebral vascular remodeling.
19  MMP, metalloproteinase
(1 time)
Toxicology
(1 time)
AR (1 time)
DBP (1 time)
PIN (1 time)
2009 Long-term effects of developmental exposure to di-n-butyl-phthalate (DBP) on rat prostate: proliferative and inflammatory disorders and a possible role of androgens.
20  MMP-9 and TIMP-1 complex
(1 time)
Neoplasms
(1 time)
DFS (1 time)
PLA (1 time)
TIMP-1 (1 time)
2013 Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
21  MMP-9 and TIMP-1 serum protein levels than healthy controls
(1 time)
Medicine
(1 time)
COPD (1 time)
TIMP-1 (1 time)
2016 Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.
22  MMP-9 CD
(1 time)
Complementary Therapies
(1 time)
alpha-SMA (1 time)
SalB (1 time)
2011 Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: inhibition by salvianolic acid B from Salvia miltiorrhiza.
23  MMP-9 downregulation
(1 time)
Cardiovascular Diseases
(1 time)
BMP-4 (1 time)
ECM (1 time)
FSS (1 time)
2015 Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.
24  MMP-9 expression to the native tissue level
(1 time)
Cardiovascular Diseases
(1 time)
BMP-4 (1 time)
ECM (1 time)
FSS (1 time)
2015 Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.
25  MMP-9 knockout
(1 time)
Psychiatry
(1 time)
CeA (1 time)
2017 Matrix Metalloproteinase-9 and Synaptic Plasticity in the Central Amygdala in Control of Alcohol-Seeking Behavior.
26  MMP-9/NGAL compared to healthy controls
(1 time)
Neoplasms
(1 time)
BMI (1 time)
NGAL (1 time)
2009 Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
27  MMP-9PL
(1 time)
Radiology
(1 time)
AAAs (1 time)
AOD (1 time)
2000 Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
28  monoclonal antibodies to human M(r) 92,000 type IV collagenase
(1 time)
Neoplasms
(1 time)
MMPs (1 time)
1993 M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
29  monocyte metalloproteinase-9
(1 time)
Allergy and Immunology
(1 time)
--- 1997 Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
30  monocyte migration and metalloproteinase-9
(1 time)
Endocrinology
(1 time)
DPP-IV (1 time)
GLP-1 (1 time)
RANTES (1 time)
2012 Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.
31  morphology; metalloproteinase-9
(1 time)
Allergy and Immunology
(1 time)
--- 2018 Exocellular extract of Fusarium oxysporum, fungus free, is able to permeate and act selectively in skin.
32  mRNA and protein levels of metalloproteinase-9
(1 time)
Complementary Therapies
(1 time)
LMPAB (2 times)
AbM (1 time)
2009 A low molecular weight polysaccharide isolated from Agaricus blazei Murill (LMPAB) exhibits its anti-metastatic effect by down-regulating metalloproteinase-9 and up-regulating Nm23-H1.
33  MYP3 expressed only a trace amount of 92-kDa gelatinase
(1 time)
Neoplasms
(1 time)
MMP-2 (1 time)
1993 Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.